1. Home
  2. CORT vs TTEK Comparison

CORT vs TTEK Comparison

Compare CORT & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • TTEK
  • Stock Information
  • Founded
  • CORT 1998
  • TTEK 1966
  • Country
  • CORT United States
  • TTEK United States
  • Employees
  • CORT N/A
  • TTEK N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • TTEK Military/Government/Technical
  • Sector
  • CORT Health Care
  • TTEK Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • TTEK Nasdaq
  • Market Cap
  • CORT 8.1B
  • TTEK 9.4B
  • IPO Year
  • CORT N/A
  • TTEK 1991
  • Fundamental
  • Price
  • CORT $71.38
  • TTEK $35.19
  • Analyst Decision
  • CORT Strong Buy
  • TTEK Buy
  • Analyst Count
  • CORT 4
  • TTEK 5
  • Target Price
  • CORT $142.00
  • TTEK $40.00
  • AVG Volume (30 Days)
  • CORT 1.4M
  • TTEK 2.1M
  • Earning Date
  • CORT 07-28-2025
  • TTEK 07-30-2025
  • Dividend Yield
  • CORT N/A
  • TTEK 0.74%
  • EPS Growth
  • CORT 8.36
  • TTEK N/A
  • EPS
  • CORT 1.14
  • TTEK 0.69
  • Revenue
  • CORT $685,446,000.00
  • TTEK $4,555,101,000.00
  • Revenue This Year
  • CORT $35.85
  • TTEK $8.15
  • Revenue Next Year
  • CORT $35.22
  • TTEK N/A
  • P/E Ratio
  • CORT $62.48
  • TTEK $50.92
  • Revenue Growth
  • CORT 30.93
  • TTEK 10.76
  • 52 Week Low
  • CORT $28.10
  • TTEK $27.27
  • 52 Week High
  • CORT $117.33
  • TTEK $51.20
  • Technical
  • Relative Strength Index (RSI)
  • CORT 48.38
  • TTEK 52.87
  • Support Level
  • CORT $69.60
  • TTEK $34.88
  • Resistance Level
  • CORT $73.13
  • TTEK $36.55
  • Average True Range (ATR)
  • CORT 3.50
  • TTEK 0.74
  • MACD
  • CORT -0.18
  • TTEK -0.16
  • Stochastic Oscillator
  • CORT 24.77
  • TTEK 46.46

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: